• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对韩国医生对低风险甲状腺癌进行主动监测情况的全国性调查。

A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea.

作者信息

Kim Min Joo, Moon Jae Hoon, Lee Eun Kyung, Song Young Shin, Jung Kyong Yeun, Lee Ji Ye, Kim Ji-Hoon, Lim Woojin, Kim Kyungsik, Park Sue K, Park Young Joo

出版信息

Eur Thyroid J. 2025 Jan 9;14(1). doi: 10.1530/ETJ-24-0281. Print 2025 Feb 1.

DOI:10.1530/ETJ-24-0281
PMID:39656545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11816037/
Abstract

OBJECTIVE

Active surveillance (AS) has emerged as a viable alternative to immediate surgery for low-risk thyroid cancer. However, several barriers still hinder its widespread adoption and implementation by physicians.

METHODS

In 2024, an email survey was conducted among members of the Korea Thyroid Association to assess their perspectives on AS. The survey comprised questions about clinical case scenarios, perceptions of the benefits and risks associated with AS, factors influencing the consideration of AS and unmet needs for the implementation of AS.

RESULTS

Among the 287 physicians surveyed, 40.8% were endocrinologists, followed by general surgeons at 20.9% and otolaryngologists at 19.9%. The majority worked in tertiary hospitals and had over 10 years of experience. Regarding a 65-year-old man with a 0.7 cm low-risk thyroid cancer, 74.6% of the respondents considered AS. Endocrinologists and physicians with higher self-assessment and experience explaining AS to patients were more inclined to consider AS. Although the respondents recognized the benefits of AS, such as avoiding surgery and reducing surgical complications, they expressed concerns about potential risks, including the possibility of patient lawsuits due to disease progression and patient worry and anxiety about the disease. Challenges in screening candidates for AS were highlighted, especially in detecting recurrent laryngeal nerve involvement and lymph node metastases. Additionally, physicians noted unmet needs in AS implementation, specifically regarding psychological support for patients and reimbursement for long-term follow-up costs.

CONCLUSIONS

The survey underscored the need for further research and initiatives to overcome the barriers and implement AS for the management of low-risk thyroid cancer.

摘要

目的

主动监测(AS)已成为低风险甲状腺癌立即手术的一种可行替代方案。然而,仍有几个障碍阻碍医生广泛采用和实施该方案。

方法

2024年,对韩国甲状腺协会成员进行了一项电子邮件调查,以评估他们对主动监测的看法。该调查包括有关临床病例场景、对主动监测相关益处和风险的认知、影响考虑主动监测的因素以及主动监测实施中未满足的需求等问题。

结果

在接受调查的287名医生中,40.8%是内分泌科医生,其次是普通外科医生,占20.9%,耳鼻喉科医生占19.9%。大多数人在三级医院工作,并有超过10年的经验。对于一名患有0.7厘米低风险甲状腺癌的65岁男性,74.6%的受访者考虑采用主动监测。内分泌科医生以及自我评估较高且有向患者解释主动监测经验的医生更倾向于考虑采用主动监测。尽管受访者认识到主动监测的益处,如避免手术和减少手术并发症,但他们也表达了对潜在风险的担忧,包括因疾病进展导致患者诉讼的可能性以及患者对疾病的担忧和焦虑。突出了筛选主动监测候选者的挑战,特别是在检测喉返神经受累和淋巴结转移方面。此外,医生指出了主动监测实施中未满足的需求,特别是在患者心理支持和长期随访费用报销方面。

结论

该调查强调需要进一步研究和采取举措,以克服障碍并实施主动监测来管理低风险甲状腺癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/02fec12e1c38/ETJ-24-0281fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/fbbd7a1d8a38/ETJ-24-0281fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/6b42eceece31/ETJ-24-0281fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/7ea72cbd5a6f/ETJ-24-0281fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/9597b6daddc9/ETJ-24-0281fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/02fec12e1c38/ETJ-24-0281fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/fbbd7a1d8a38/ETJ-24-0281fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/6b42eceece31/ETJ-24-0281fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/7ea72cbd5a6f/ETJ-24-0281fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/9597b6daddc9/ETJ-24-0281fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/11816037/02fec12e1c38/ETJ-24-0281fig5.jpg

相似文献

1
A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea.一项针对韩国医生对低风险甲状腺癌进行主动监测情况的全国性调查。
Eur Thyroid J. 2025 Jan 9;14(1). doi: 10.1530/ETJ-24-0281. Print 2025 Feb 1.
2
Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.美国对极低风险分化型甲状腺癌采用主动监测:一项全国性调查。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1728-e1737. doi: 10.1210/clinem/dgaa942.
3
Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.与医生推荐低危型甲状腺乳头状癌管理方案相关的因素。
Am J Surg. 2021 Jul;222(1):111-118. doi: 10.1016/j.amjsurg.2020.11.021. Epub 2020 Nov 12.
4
Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change.低风险甲状腺微小乳头状癌的主动监测:关于临床医生对变革准备情况的网络调查
Eur Thyroid J. 2025 Mar 17;14(2). doi: 10.1530/ETJ-25-0013. Print 2025 Apr 1.
5
NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.全国内分泌学家和外科医生关于低危甲状腺乳头状癌主动监测的调查。
Endocr Pract. 2021 Jan;27(1):1-7. doi: 10.1016/j.eprac.2020.11.003. Epub 2020 Nov 17.
6
Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.促甲状腺激素抑制治疗用于甲状腺乳头状癌:一项医师调查研究。
Thyroid. 2021 Sep;31(9):1383-1390. doi: 10.1089/thy.2021.0033. Epub 2021 Apr 23.
7
Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.主动监测甲状腺癌:实施障碍和促进因素的定性研究。
BMC Cancer. 2021 Apr 28;21(1):471. doi: 10.1186/s12885-021-08230-8.
8
Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.主动监测与即刻手术:日本低危型甲状腺微小乳头状癌成年患者当前治疗策略的问卷调查
Thyroid. 2019 Nov;29(11):1563-1571. doi: 10.1089/thy.2019.0211. Epub 2019 Sep 25.
9
Patient Experience of Thyroid Cancer Active Surveillance in Japan.日本甲状腺癌主动监测患者体验。
JAMA Otolaryngol Head Neck Surg. 2019 Apr 1;145(4):363-370. doi: 10.1001/jamaoto.2018.4131.
10
REFERRAL OF OLDER THYROID CANCER PATIENTS TO A HIGH-VOLUME SURGEON: RESULTS OF A MULTIDISCIPLINARY PHYSICIAN SURVEY.将老年甲状腺癌患者转诊至高手术量外科医生:多学科医生调查结果
Endocr Pract. 2017 Jul;23(7):808-815. doi: 10.4158/EP171788.OR. Epub 2017 May 23.

引用本文的文献

1
2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma.2025年韩国甲状腺协会低风险乳头状甲状腺癌主动监测临床管理指南
Endocrinol Metab (Seoul). 2025 Jun;40(3):307-341. doi: 10.3803/EnM.2025.2461. Epub 2025 Jun 24.

本文引用的文献

1
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review.主动监测低危型甲状腺乳头状癌作为一种可接受的治疗选择,具有额外获益:全面系统综述。
Endocrinol Metab (Seoul). 2024 Feb;39(1):152-163. doi: 10.3803/EnM.2023.1794. Epub 2024 Jan 22.
2
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.主动监测低危甲状腺癌:当前实践指南综述。
Endocrinol Metab (Seoul). 2024 Feb;39(1):47-60. doi: 10.3803/EnM.2024.1937. Epub 2024 Feb 15.
3
Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
主动监测与即刻手术治疗低危型甲状腺微小乳头状癌成人患者的长期疗效:30 年经验
Thyroid. 2023 Jul;33(7):817-825. doi: 10.1089/thy.2023.0076. Epub 2023 May 29.
4
Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma.欧洲癌症研究与治疗组织(EORTC)内分泌特别工作组关于低风险微小乳头状甲状腺癌患者管理及共同决策的立场文件。
Eur J Cancer. 2023 Jan;179:98-112. doi: 10.1016/j.ejca.2022.11.005. Epub 2022 Nov 15.
5
Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.低危型甲状腺微小癌主动监测中的进展:韩国多中心前瞻性甲状腺微小癌主动监测队列研究的中期分析。
Thyroid. 2022 Nov;32(11):1328-1336. doi: 10.1089/thy.2021.0614.
6
Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.促甲状腺激素、年龄和肿瘤大小是成人低危甲状腺微小乳头状癌主动监测期间进展的危险因素。
World J Surg. 2023 Feb;47(2):392-401. doi: 10.1007/s00268-022-06770-z. Epub 2022 Oct 2.
7
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro).一项关于甲状腺微小乳头状癌主动监测的多中心前瞻性队列研究(MAeSTro)中的患者治疗选择的横断面调查。
Thyroid. 2022 Jul;32(7):772-780. doi: 10.1089/thy.2021.0619.
8
Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US.美国低危甲状腺乳头状癌过度诊断和过度治疗的医生观点。
JAMA Netw Open. 2022 Apr 1;5(4):e228722. doi: 10.1001/jamanetworkopen.2022.8722.
9
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020.全球甲状腺癌的流行病学概况:2020 年发病率和死亡率的 GLOBOCAN 估计。
Lancet Diabetes Endocrinol. 2022 Apr;10(4):264-272. doi: 10.1016/S2213-8587(22)00035-3. Epub 2022 Mar 7.
10
A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.定量分析探讨了低危型甲状腺乳头状癌患者选择主动监测还是手术治疗的情况。
Thyroid. 2022 Mar;32(3):255-262. doi: 10.1089/thy.2021.0485. Epub 2022 Feb 17.